Systematic Review on Heart Rate Variability (HRV) among Prediabetics Aged 45-60 Years
DOI:
https://doi.org/10.37506/95qdsx09Keywords:
“HRV,” “prediabetes,” “autonomic dysfunction,” “middle-aged.” “Time-domain HRV”, “Frequency domain HRV”, “Dysautonimia”, “T2DMAbstract
Heart Rate Variability (HRV) is an established non-invasive marker used to assess autonomic nervous system (ANS) function. Recent studies have highlighted the potential role of HRV as an early indicator of metabolic dysfunction in prediabetes, particularly for middle-aged individuals. The early age detection will help in early treatment and prevention of dysautonomia like neuropathy, retinopathy. Early diagnosis of dysautonomia can potentially lead to a better prognosis and quality of life. This systematic review aims to highlight the current researches on HRV in prediabetic populations aged 45–60 years, exploring the relationship between reduced HRV and early cardiovascular autonomic dysfunction. Studies employing traditional HRV measures are used to identify the predictive value of HRV in prediabetes and the progression to Type 2 Diabetes Mellitus (T2DM) in middle aged individuals using PRISMA guidelines with two independent reviewers assessing the quality of included studies. The studies have shown a high corelation between heart rate variability (HRV) and prediabetes among individuals aged 45-60 years (middle aged).HRV could be used as a predictor of dysautonomia in prediabetic individuals for progression of diabetes (T2DM)
References
Benichou T, Pereira B, Mermillod M, Tauveron I, Pfabigan D, Maqdasy S, et
al. Heart rate variability in type 2 diabetes mellitus: a systematic review and
meta-analysis. Diabetologia. 2018;61(6):1175-1184.
2. Ganji M, Abadeh MS. An absolute magnitude deviation of HRV for the
prediction of prediabetes with combined artificial neural network and
regression tree method. Comput Methods Programs Biomed. 2019;176:147-
154.
3. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective
investigation of autonomic nervous system function and the development of
type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987-
1998. Circulation. 2003;107(17):2190-2195.
4. Ribeiro LF, Macedo AP, Xavier JC, Alves MJNF, Barbosa ER. Heart rate
variability in prediabetes and type 2 diabetes: A systematic review and meta-
analysis. Diabetes Res Clin Pract. 2021;176:108823.
5. Ziegler D, Varga S, Rohling M, Strom A. Cardiac autonomic dysfunction in
prediabetes and diabetes: Association with subclinical inflammation and
peripheral neuropathy. Diabetes Care. 2018;41(3):654-660.
6. Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and
norms. Front Public Health. 2017;5:258.
7. Liao D, Carnethon M, Evans GW, Cascio WE, Heiss G. Lower heart rate
variability is associated with the development of coronary heart disease in
individuals with diabetes: the ARIC study. Diabetes. 2002;51(12):3524-3531.
8. Thiyagarajan R, John SM, Krishna Kumar R. Heart rate variability in
prediabetes and diabetes: A study on autonomic function. J Diabetol.
2012;3(1):1-6.
9. Wang C, Li J, Xie Y. Association between heart rate variability and
prediabetes: A systematic review and meta-analysis. J Diabetes Res.
2017;2017:9348216.
10. Kiselev J, Suija K, Oona M, Mellenthin E, et al. Association of HRV among
prediabetics. J Integrative Med. 2018. Available
from: https://www.ncbi.nlm.nih.gov
11. Gulumbe et al. Predicting neural damage among diabetics and
prediabetics. Diabetes MetabSyndr. 2019;13(1):121-126.
12. Smith et al., Patel et al. Intensive blood glucose control and vascular outcomes
in patients with type 2 diabetes. Lancet. [Year missing].
13. Huang Y, Huang X, Zhong L, Yang J. Glycated haemoglobin index is a new
predictor for all-cause mortality and cardiovascular mortality in
adults. Diabetes Care. 2020;43(4):837-844.
14. Fox CS. Cardiovascular disease risk factors, type 2 diabetes mellitus, and the
Framingham Heart Study. Trends Cardiovasc Med. 2010;20(3):90–95.
15. Laakso M. Cardiovascular disease in type 2 diabetes: From population to man
to mechanisms: The Kelly West Award Lecture 2008. Diabetes Care.
2010;33(4):742-747.
16. Tancredi M, Rosengren A, Svensson A-M, Kosiborod M, Pivodic A,
Gudbjörnsdottir S, et al. Excess mortality among persons with type 2
diabetes. N Engl J Med. 2015;373(18):1720-1732.
17. Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a
cohort study in 1.9 million people. Lancet Diabetes Endocrinol.
2015;3(6):470-477.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Ownership: Authors retain copyright ownership of their work after publication in IJOP. However, they grant the journal an exclusive Creative Commons license.
Creative Commons License: The authors grant IJOP the right to exclusively apply a Creative Commons license to their work upon publication. This license permits use, distribution, and reproduction of the work in any medium, provided that the original work and its source are properly cited. The specific license applied is Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which allows for attribution, non-commercial use, and derivative works.
Editorial Research: Authors grant the journal the right to analyze information obtained from submitted manuscripts for editorial research purposes. This analysis aims to improve the peer-review process, teaching, and training activities.
Warranties: Authors warrant that their work is original, contains no libelous statements, is lawful, and does not infringe upon any copyright, trademark, patent, or proprietary rights of others. Authors agree to indemnify the editors against any costs, expenses, and damages arising from any breach of this warranty.
Views and Opinions: The views and opinions expressed in the article are those of the authors and not necessarily those of the journal.